share_log

德康農牧:內幕消息 - 盈利預喜

DEKON AGR: INSIDE INFORMATION - POSITIVE PROFIT ALERT

HKEX ·  Aug 12 13:36

Summary by Futu AI

德康農牧(「本公司」)於2024年8月12日發布內幕消息,預告截至2024年6月30日止六個月的財務業績將顯著好轉。根據初步評估,本集團預計將錄得生物資產公允價值調整前利潤約人民幣313百萬元至413百萬元,及淨純利約人民幣1,713百萬元至1,813百萬元。此一轉變與2023年同期相比,當時錄得生物資產公允價值調整前虧損約人民幣1,118百萬元及淨虧損約人民幣2,353百萬元,顯示本集團業績由虧轉盈。業績改善主要由於商品豬與黃羽肉雞的銷售價格上漲,以及生產管理及成本控制的持續改善。本公司將於2024年8月底前發布中期業績公告,屆時將提供更多財務詳情。公司股東及潛在投資者應審慎行事。
德康農牧(「本公司」)於2024年8月12日發布內幕消息,預告截至2024年6月30日止六個月的財務業績將顯著好轉。根據初步評估,本集團預計將錄得生物資產公允價值調整前利潤約人民幣313百萬元至413百萬元,及淨純利約人民幣1,713百萬元至1,813百萬元。此一轉變與2023年同期相比,當時錄得生物資產公允價值調整前虧損約人民幣1,118百萬元及淨虧損約人民幣2,353百萬元,顯示本集團業績由虧轉盈。業績改善主要由於商品豬與黃羽肉雞的銷售價格上漲,以及生產管理及成本控制的持續改善。本公司將於2024年8月底前發布中期業績公告,屆時將提供更多財務詳情。公司股東及潛在投資者應審慎行事。
On August 12, 2024, Dekang Agriculture and Animal Husbandry ("the Company") released insider information that the financial performance for the six months ending June 30, 2024 will significantly improve. According to preliminary assessment, the Group expects to record a pre-adjusted profit in biological assets of approximately RMB 313 million to RMB 413 million, and a net profit of approximately RMB 1.713 billion to RMB 1.813 billion. This change compared with the same period in 2023, when a pre-adjusted loss of approximately RMB 1.118 billion and a net loss of approximately RMB 2.353 billion were recorded in biological assets, shows that the Group's performance has turned from loss to profit. The improvement in performance is mainly due to the rising sales prices of commodity pigs and yellow broilers, as well as the continuous improvement in production management and cost control. The Company will release a mid-term performance announcement before the end of August 2024, providing more detailed financial information. Shareholders and potential investors of the Company should act prudently.
On August 12, 2024, Dekang Agriculture and Animal Husbandry ("the Company") released insider information that the financial performance for the six months ending June 30, 2024 will significantly improve. According to preliminary assessment, the Group expects to record a pre-adjusted profit in biological assets of approximately RMB 313 million to RMB 413 million, and a net profit of approximately RMB 1.713 billion to RMB 1.813 billion. This change compared with the same period in 2023, when a pre-adjusted loss of approximately RMB 1.118 billion and a net loss of approximately RMB 2.353 billion were recorded in biological assets, shows that the Group's performance has turned from loss to profit. The improvement in performance is mainly due to the rising sales prices of commodity pigs and yellow broilers, as well as the continuous improvement in production management and cost control. The Company will release a mid-term performance announcement before the end of August 2024, providing more detailed financial information. Shareholders and potential investors of the Company should act prudently.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.